Joint replacements are the #1 expenditure of Medicare. The process of approving these medical devices is flawed according to the Institute of Medicine. It is time for patients' voices to be heard as stakeholders and for public support for increased medical device industry accountability and heightened protections for patients. Post-market registry. Product warranty. Patient/consumer stakeholder equity. Rescind industry pre-emptions/entitlements. All clinical trials must report all data.
Please share what you have learned!
Twitter: @JjrkCh

Tuesday, August 23, 2011

(Failed medical device) Patients whose future is so uncertain . . .

J&J DePuy ASR hip recall - corporate "Plan B"   Press on this link for Reuters article 8/22/11

"Insight: DePuy's handling of hip recall sparks questions"

Doctors are paid a $50 "bounty" to encourage patients to fill out a form that may
conflict with their civil rights in court proceedings.

A elderly woman walks along a corridor in a file photo. REUTERS/Michaela Rehle

No comments:

Post a Comment